Skip to content Skip to footer

About mbiomics

ABOUT

mbiomics offers a unique combination of fast, quantitave and accurate analysis of the microbiome.

mbiomics is a pioneer in targeted microbiome profiling. Our patented precision technology enables unparalleled quantitative resolution and drastically faster microbiome analysis. This creates a basis for various future clinical applications and it will accelerate microbiome-based therapeutics development.

Our partners

We work with industry leaders across the medical, technology and biotechnology industries, as well as renowned academic institutions, on both clinical research and commercial product development.

University of Zurich
Rebiotix

Founders

Dr. Laura Figulla

CEO | Co-Founder

Dr. Markus Rinecker

CMO/CFO | Co-Founder

Dr. Johannes B. Woehrstein

CTO | Co-Founder

Dr. Heinrich Grabmayr

Co-Founder

WHITEPAPER

How to accelerate bacterial profiling and microbiome analysis.

    mbiomics GmbH

    Kistlerhofstr. 70
    Building 79
    81379 Munich, Germany

    info@mbiomics.com

    +49 89 7199 8662

    Get In Touch

    mbiomics © 2022. All Rights Reserved.